Mitochodrial DNA and diseases of the nervous system: The spectrum

Neuroscientist

Volumn 4, Issue 1, 1998, Pages 53-63

  Dimauro, Salvatore ^a   Schon, Eric A ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Mitochondria; Mitochondrial DNA (mtDNA); Mitochondrial encephalomyopathies

Indexed keywords

MITOCHONDRIAL DNA;

CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENCEPHALOMYOPATHY; GENE MUTATION; GENE REARRANGEMENT; GENE STRUCTURE; KEARNS SAYRE SYNDROME; LEIGH DISEASE; NEUROPATHOLOGY; NEUROPATHY; PATHOPHYSIOLOGY; POINT MUTATION; RETINITIS PIGMENTOSA; REVIEW;

EID: 0031814491     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849800400113     Document Type: Review

References (60)

1. Nass S, Nass M. Intramitochondrial fibers with DNA characteristics. J Cell Biol 1963;19:593-629.
2. Holt IJ, Harding AE, Morgan Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719.
3. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-1430.
4. DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann; 1997. p. 201-235.
5. Schon EA. The mitochondrial genome. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann; 1997. p. 189-200.
6. Cann RL, Stoneking M, Wilson AC. Mitochondrial DNA and human evolution. Nature 1987;325:31-36.
7. Wallace DC, Zheng X, Lott MT, et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological and biochemical characterization of a mitochondrial DNA disease. Cell 1988;55:601-610.
8. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmoplegia, and complete heart block. Arch Ophthalmol 1958;60: 280-289.
9. Rowland LP, Blake D, Hirano M, et al. Clinical syndromes associated with ragged red fibers. Rev Neurol (Paris) 1991;147:467-473.
10. Zeviani M, Moraes CT, DiMauro S. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38:1339-1346.
11. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-1299.
12. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990;86:1601-1608.
13. Hirano M, DiMauro S. Clinical features of mitochondrial myopathies and encephalomyopathies. In: Lane RJM, editor. Handbook of muscle disease. New York: Marcel Dekker; 1996. p. 479-504.
14. Shoffner JM, Lott MT, Lezza A, et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990;61:931-937.
15. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653.
16. Holt IJ, Harding AE, Petty RK, Morgan Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-433.
17. Santorelli FM, Shanske S, Macaya A, et al. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh syndrome. Ann Neurol 1993;34:827-834.
18. Anan R, Nakagawa M, Miyata M, et al. Cardiac involvement in mitochondrial diseases. A study of 17 patients with mitochondrial DNA defects. Circulation 1995;91:955-961.
19. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-968.
20. El-Schahawi M, Lopez de Munain A, Sarrazin AM, et al. Two large Spanish pedigrees with nonsyndromic deafness and the mtDNA mutation at nt 1555 in the 12S rRNA gene: evidence of heteroplasmy. Neurology 1997;48:453-456.
21. Luft R. The development of mitochondrial medicine. Proc Natl Acad Sci U S A 1994;91:8731-8738.
22. Ernster L, Ikkos D, Luft R. Enzymic activities of human skeletal muscle mitochondria: a tool in clinical metabolic research. Nature 1959;184:1851-1854.
23. Moraes CT, Zeviani M, Schon EA, et al. Mitochondrial DNA deletion in a girl with features of Kearns Sayre and Lowe syndromes: an example of phenotypic mimicry? Am J Med Genet 1991;41:301-305.
24. Goto Y, Itami N, Kajii N, et al. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr 1990;116:904-910.
25. Rotig A, Cormier V, Chatelain P, et al. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Clin Invest 1992;91:1095-1098.
26. Uziel G, Moroni I, Lamantea E, et al. Mitochondrial disease associated with the T8993G mutation of mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 1997;63:16-22.
27. Harding AE, Sweeney MG, Miller DH, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115:979-989.
28. Parker WD, Oley CA, Parks JK. A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. N Engl J Med 1989;320: 1331-1333.
29. Larsson NG, Anderson O, Holme E, et al. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol 1991; 30:701-708.
30. Vazquez-Memije ME, Shanske S, Santorelli FM, et al. Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis 1996;19:43-50.
31. King MP, Koga Y, Davidson M, Schon EA. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Mol Cell Biol 1992;12:480-490.
32. Kaufmann P, Koga Y, Shanske S, et al. Mitochondrial DNA and RNA processing in MELAS. Ann Neurol 1996;40:172-180.
33. Santorelli FM, Mak S-C, Vazquez-Memije ME, et al. Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 1996;39:914-917.
34. Petruzzella V, Moraes CT, Sano MC, et al. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 1994;3:449-454.
35. Shanske S, Moraes CT, Lombes A, et al. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology 1990;40:24-28.
36. McShane MA, Hammans SR, Sweeney M, et al. Pearson syndrome and mitochondrial encephalopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991;48:39-42.
37. Larsson NG, Holme B, Kristiansson B. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990;28:131-136.
38. Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993;52:1-10.
39. Sparaco M, Schon EA, DiMauro S, Bonilla E. Myoclonic epilepsy with ragged-red fibers (MERRF): an immunohistochemical study of the brain. Brain Pathol 1995;5:125-133.
40. Mita S, Schmidt B, Schon EA, et al. Detection of "deleted" mitochondrial genomes in cytochrome-c-oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc Natl Acad Sci USA 1989;86:9509-9513.
41. Cortopassi GA, Shibata D, Soong NW, Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci U S A 1992;89:7370-7374.
42. Wallace DC. Mitochondrial DNA mutations and bioenergetic defects in aging and degenerative diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann; 1997. p. 237-269.
43. Pallotti F, Chen X, Bonilla E, Schon EA. Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging. Am J Hum Genet 1996;59:591-602.
44. Beal F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366.
45. Lin FH, Lin R, Wisniewski HM, et al. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun 1992;182:238-246.
46. Petruzzella V, Chen X, Schon EA. Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease? Biochem Biophys Res Commun 1992;186:491-497.
47. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993;17:171-184.
48. Horton TM, Graham BH, Corral-Debrinski M, et al. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients. Neurology 1995;45:1879-1883.
49. Chen X, Bonilla E, Sciacco M, Schon EA. Paucity of deleted mitochondrial DNAs in brain regions of Huntington's disease patients. Biochim Biophys Acta 1995;1271:229-233.
50. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671.
51. Silvestri G, Santorelli FM, Shanske S, et al. A new mtDNA mutation in the tRNA(LeuUUR) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994;3:37-43.
52. Goto Y, Tojo M, Tohyama J, et al. A novel point mutation in the mitochondrial tRNALeu(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 1992;31:672-675.
53. Ogle RF, Christodoulou J, Fagan E, et al. Mitochondrial myopathy with tRNALeu(UUR) mutation and complex I deficiency responsive to riboflavin. J Pediatr 1997;130:138-145.
54. Santorelli FM, Schlessel JS, Slonim AE, DiMauro S. Novel mutation in the mitochondrial DNA tRNA glycine gene associated with sudden unexpected death. Pediatr Neurol 1996;15:145-149.
55. Minshew NJ, Goldstein G, Dombrowski SM, et al. A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry 1993; 33:762-773.
56. Suomalainen A, Majander A, Haltia M, et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992;90:61-66.
57. Suomalainen A, Kaukonen J, Amati P, et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 195; 9:146-151.
58. Santorelli FM, Tanji K, Sano M, et al. Maternally inherited encephalopathy associated with a single-base insertion in the mitochondrial tRNATrp gene. Ann Neurol 1997;41:256-260.
59. McMahon FJ, Stine OC, Meyers DA, et al. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 1995; 56:1277-1286.
60. Taylor RF, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrdial DNA replication in vitro by peptide nucleic acids. Nat Genet 1997;15:212-215.